Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endogenous production of specific antibodies does not decrease hypocalcemic response to calcitonin in young rabbits.

J Y Reginster1, M Azria, S Gaspar

  • 1Bone Metabolism Unit, University of Liege, Policliniques Universitaires Lucien Brull, Belgium.

Calcified Tissue International
|June 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2003
Same author

Structure of bacteriocin AS-48: from soluble state to membrane bound state.

Journal of molecular biology·2003
Same author

Crural artery bypass with the autogenous greater saphenous vein.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2003
Same author

[Predictive value of prenatal MRI in the diagnosis of thoracic congenital malformations].

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2003
Same author

Weekly paclitaxel for advanced non-small cell lung cancer patients not suitable for platinum-based therapy.

Neoplasma·2003
Same author

Factors predictive of nephropathy in DCCT Type 1 diabetic patients with good or poor metabolic control.

Diabetic medicine : a journal of the British Diabetic Association·2003
Same journal

ODAPH (p.Arg77*) Phenotype and Onset of Ameloblast Pathology During Postsecretory Transition Demonstrated by FIB-SEM Analyses of Odaph<sup>C41*/C41*</sup> Mice.

Calcified tissue international·2026
Same journal

Cytokine Networks Reprogramming the Osteo-Immune Microenvironment in Cancer Bone Metastasis.

Calcified tissue international·2026
Same journal

Associations between controlling nutritional status and mortality in osteoporosis: evidence from NHANES, 2005-2018.

Calcified tissue international·2026
Same journal

Gut Microbiota-Derived TMAO Drives MC3T3-E1 Senescence and Osteogenic Dysfunction via cGAS-STING-NF-κB Signaling: Implications for Age-Related Bone Loss.

Calcified tissue international·2026
Same journal

Artificial Intelligence Approaches for Osteoporotic Fracture Risk Prediction Using Administrative Health Data: A Systematic Review.

Calcified tissue international·2026
Same journal

The Important Role of Polycystin in the Skeletal System.

Calcified tissue international·2026
See all related articles

Specific antibodies against salmon calcitonin (SCT) did not inhibit its acute anti-osteoclastic activity in young male rabbits. The hypocalcemic effect of SCT remained similar in rabbits with high-affinity antibodies and those without.

Area of Science:

  • Endocrinology
  • Immunology
  • Pharmacology

Background:

  • Salmon calcitonin (SCT) is known for its acute anti-osteoclastic activity.
  • The potential for specific antibodies (Ab) to inhibit SCT's therapeutic effects is a relevant consideration.

Purpose of the Study:

  • To evaluate whether specific antibodies against salmon calcitonin (SCT) can inhibit its acute anti-osteoclastic activity.
  • To compare the hypocalcemic effect of SCT in rabbits with and without high-affinity anti-SCT antibodies.

Main Methods:

  • Young male rabbits were immunized to develop specific anti-SCT antibodies (Ab+).
  • A control group of rabbits without antibodies (Ab-) was established.
  • The hypocalcemic effect of intravenous SCT injection (1 IU/kg) was measured by monitoring ionized serum calcium (Ca2+) levels over time in both groups.

Related Experiment Videos

Main Results:

  • Rabbits with anti-SCT antibodies (Ab+) showed a significant decrease in Ca2+ post-SCT injection, comparable to rabbits without antibodies (Ab-).
  • The timing and magnitude of the maximal hypocalcemic effect were not significantly different between the Ab+ and Ab- groups.
  • Specific anti-SCT antibodies did not block or reduce the acute hypocalcemic (anti-osteoclastic) activity of SCT in this rabbit model.

Conclusions:

  • In young male rabbits, specific anti-SCT antibodies do not interfere with the acute anti-osteoclastic effects of SCT.
  • The study suggests that antibody formation against SCT may not be a significant barrier to its short-term therapeutic efficacy in this model.